Study identifier:SD-037-0695
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
The safety and efficacy profiles of Oxis (formoterol) Turbuhaler as needed and Bricanyl (terbutaline) Turbuhaler as needed in children with asthma on anti-inflammatory treatment.
asthma
Phase 3
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|